Toshiyuki Ohtani Selected Research

Sarin

12/2009	Smaller amygdala volume and reduced anterior cingulate gray matter density associated with history of post-traumatic stress disorder.
1/2007	Human brain structural change related to acute single exposure to sarin.
4/2006	Voxel-based diffusion tensor analysis reveals aberrant anterior cingulum integrity in posttraumatic stress disorder due to terrorism.
3/2005	Association between lower P300 amplitude and smaller anterior cingulate cortex volume in patients with posttraumatic stress disorder: a study of victims of Tokyo subway sarin attack.
9/2003	Hypoactivation of the prefrontal cortex during verbal fluency test in PTSD: a near-infrared spectroscopy study.
7/2003	Activation of the prefrontal cortex to trauma-related stimuli measured by near-infrared spectroscopy in posttraumatic stress disorder due to terrorism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshiyuki Ohtani Research Topics

Disease

6	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2009 - 07/2003
3	Schizophrenia (Dementia Praecox) 03/2016 - 07/2004
2	Neoplasms (Cancer) 04/2013 - 07/2007
2	Glioblastoma (Glioblastoma Multiforme) 04/2013 - 07/2007
2	Mental Disorders (Mental Disorder) 01/2008 - 07/2004
2	Bipolar Disorder (Manic Depressive Psychosis) 12/2007 - 07/2004
1	Blister (Bulla) 01/2021
1	Rupture 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Ischemic Stroke 12/2019
1	Atrial Fibrillation 12/2019
1	Dysarthria (Spastic Dysarthria) 12/2019
1	Paresis (Hemiparesis) 12/2019
1	Stroke (Strokes) 12/2019
1	Lacunar Stroke 12/2019
1	Psychotic Disorders (Schizoaffective Disorder) 03/2016
1	Anaplasia 07/2007
1	Neurobehavioral Manifestations 01/2007
1	Anxiety Disorders (Anxiety Disorder) 08/2006
1	Alzheimer Disease (Alzheimer's Disease) 07/2004
1	Parkinson Disease (Parkinson's Disease) 07/2004
1	Wounds and Injuries (Trauma) 07/2003

Drug/Important Bio-Agent (IBA)

6	SarinIBA 12/2009 - 07/2003
2	Biological ProductsIBA 12/2009 - 01/2008
2	Hemoglobins (Hemoglobin)IBA 09/2003 - 07/2003
1	Dabigatran FDA Link 12/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2019
1	idarucizumabIBA 12/2019
1	Methamphetamine (Desoxyn)FDA LinkGeneric 03/2016
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2013
1	YM 872IBA 04/2013
1	6,7-dimethoxy-3-phenylquinoxalineIBA 04/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2013
1	Carbon DioxideIBA 12/2007
1	Glutamic Acid (Glutamate)FDA Link 07/2007
1	Glutamate Receptors (Glutamate Receptor)IBA 07/2007
1	Complementary DNA (cDNA)IBA 07/2007
1	AMPA Receptors (AMPA Receptor)IBA 07/2007
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 07/2007
1	OrganophosphatesIBA 01/2007
1	Corticotropin-Releasing HormoneIBA 08/2006
1	DNA (Deoxyribonucleic Acid)IBA 07/2004

Therapy/Procedure

1	Stents 01/2021
1	Thrombolytic Therapy 12/2019
1	Therapeutics 04/2013
1	Aftercare (After-Treatment) 04/2013